Urogen Pharma, INC.
Biopharmaceutical company
Based in NJ
🤖
AI Overview
With $470K in lobbying spend across 16 quarterly filings, Urogen Pharma, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
$470K
Total Spend
4
Years Active
1
Firms Hired
4
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $140K |
| 2023 | $120K |
| 2024 | $90K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.